Taurine induces upregulation of p53 and Beclin1 and has antitumor effect in human nasopharyngeal carcinoma cells in vitro and in vivo

Autor: Okano, Motohiko, He, Feng, Ma, Ning, Kobayashi, Hatasu, Oikawa, Shinji, Nishimura, Komei, Tawara, Isao, Murata, Mariko

Publikováno v: In Acta Histochemica January 2023 125(1)

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pravastatin prevents colitis-associated carcinogenesis by reducing CX3CR1 ^high M2-like fibrocyte counts in the inflamed colon.

Autor: Hachiya K; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, 514-8507, Mie, Japan.; Department of Signal Transduction, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka, Japan., Masuya M; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, 514-8507, Mie, Japan. mmasuya@med.mie-u.ac.jp.; Course of Nursing Science, Mie University Graduate School of Medicine, Tsu, 514-8507, Mie, Japan. mmasuya@med.mie-u.ac.jp., Kuroda N; Department of Gastroenterology, Saiseikai Matsusaka General Hospital, Matsusaka, 515- 8557, Mie, Japan., Yoneda M; Department of Clinical Nutrition Medical Technology Course, Suzuka University of Medical Science, Suzuka, 510-0293, Mie, Japan., Nishimura K; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, 514-8507, Mie, Japan., Shiotani T; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, 514-8507, Mie, Japan., Tawara I; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, 514-8507, Mie, Japan., Katayama N; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, 514-8507, Mie, Japan.

Publikováno v: Scientific reports [Sci Rep] 2024 Oct 03; Vol. 14 (1), pp. 23021. Date of Electronic Publication: 2024 Oct 03.

[A hemolytic episode following COVID-19 in a case with atypical hemolytic uremic syndrome].

Autor: Suzuki K; Department of Hematology and Oncology, Mie University Hospital., Nagaharu K; Department of Hematology and Oncology, Mie University Hospital., Hachiya K; Department of Hematology and Oncology, Mie University Hospital., Nishimura K; Department of Hematology and Oncology, Mie University Hospital., Matsumoto T; Department of Transfusion Medicine and Cell Therapy, Mie University Hospital., Tawara I; Department of Hematology and Oncology, Mie University Hospital.

Publikováno v: [Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2022; Vol. 63 (3), pp. 224-228.